Bialostockie Centrum Onkologii Oddzial Onkologii Ginekologicznej

Bialystok 20-081

0 studies enrolling now · 1 studies all time

What they study most

Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Partial Response, Primary Peritoneal

Studies at this site

• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling